Study On Problems And Countermeasures Of Chinese Traditional Medicine Formula Granule Industry

Chinese medicine is an important part of the world's medical field,especially in the treatment of disease,chronic diseases and other advantages.The decoction of traditional Chinese medicine decoction pieces is clinically the most commonly used clinical drug form.However,disadvantages such as time-consuming decocting and inconvenience in carrying can not adapt to the modern fast-paced life.It is urgently needed to reform the traditional decoction formulations.The traditional Chinese medicine formula granules are one of the new formulations.With the promulgation of the Measures for the Administration of Chinese Medicinal Formula Granules(Draft for Soliciting Opinions),the existing pilot production may be open,and there will be more room for development of Chinese herbal formula granules.The first part of the thesis summarizes the status of China's traditional Chinese medicine formulation granule industry,briefly describes the origin and development of traditional Chinese medicine formula granules,analyzes the advantages of traditional Chinese medicine formula granules,and analyzes the profile,clinical application and national supervision status of the six pilot enterprises.The second part analyzes the development status of traditional Chinese medicine formula granules in Japan and Taiwan in China.The main research contents are the development status,clinical use and supervision of traditional Chinese medicine formulation granules industry in Japan and Taiwan,and compare the industry status quo of traditional Chinese medicine formula granules.Can promote China's advanced experience in the development of traditional Chinese medicine formula granules.The third part mainly analyzes the problems existing in the traditional Chinese medicine formula granule industry.Analyze from the four aspects of production,circulation,clinical application,and national supervision and management.The main problems in the production are raw material problems,production process problems,and packaging problems.There are mainly Internet sales and tendering issues in circulation;clinical use mainly includes incomplete varieties,equivalence issues,high prices,and failure to include medical insurance.There are deviations in patient's cognition;national supervision issues include lack of national-level quality standards,inadequate supervision systems,and industry monopolies.The fourth part mainly aims at the problems existing in the traditional Chinese medicine formula granule industry,and puts forward corresponding suggestions and countermeasures.In terms of production,it strictly controls the quality of raw Chinese herbal medicines,establishes its own GAP planting base for traditional Chinese medicines,and optimizes production techniques;in terms of circulation,it severely cracks down on illegal Internet sales,establishes a sound procurement system,and accelerates equivalence research in clinical use.The Chinese medicine formula granules were included in the medical insurance;in the aspect of national supervision,a unified national standard was established,the supervision system was perfected,and pilots were appropriately opened.